Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 16/20 | 0.78 |
| ▸ | ABCB1 | P08183 | 9/20 | 0.78 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8807296 | 0.98 | ABCG2 (0.79) | ABCG2ABCB1MAOBCYP1A2CYP2C8 | |
| SCHEMBL8806668 | 0.90 | ABCG2 (0.89) | ABCG2ABCB1CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL8809128 | 0.89 | ABCG2 (0.91) | ABCG2ABCB1CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL8812275 | 0.86 | ABCG2 (0.71) | ABCG2ABCB1CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL8806884 | 0.85 | ABCB1 (0.57) | ABCG2ABCB1MAOBCYP1A2CYP2C8 | |
| SCHEMBL8809580 | 0.82 | ABCB1 (0.59) | ABCG2ABCB1MAOB | |
| SCHEMBL8808199 | 0.82 | ABCG2 (0.74) | ABCG2ABCB1CYP1A2CYP2C8CYP2D6 | |
| SCHEMBL8809186 | 0.81 | ABCG2 (0.78) | ABCG2ABCB1MAOBCYP1A2CYP2C8 | |
| SCHEMBL8809428 | 0.80 | ABCB1 (0.89) | ABCG2ABCB1 | |
| SCHEMBL8807711 | 0.79 | ABCB1 (0.59) | ABCG2ABCB1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5663179-A | CAN SENSITIZE MULTIDRUG RESISTANT CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS | LABORATOIRES GLAXO SA (FR) | 1997-09-02 | — | — | US | disclosed |
| EP-0649410-B1 | ANILIDE DERIVATIVES | GLAXO LAB SA (FR) | 1997-05-02 | — | — | EP | disclosed |